Health-related quality of life in patients with dual diagnosis: clinical correlates

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Benaiges, Irina ^a   Prat, Gemma ^a   Adan, Ana ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institute for Brain Cognition and Behavior (IR3C)   (Spain)

Author keywords

Dual diagnosis; Health related quality of life; Quality of life; Severe mental illness; Substance use

Indexed keywords

ADULT; ARTICLE; COFFEE; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; QUALITY OF LIFE; SHORT FORM 36; SUICIDE ATTEMPT; ADDICTION; COMPARATIVE STUDY; HEALTH SURVEY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS;

CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS;

EID: 84865648185     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-106     Document Type: Article

References (44)

1. Zubaran C, Foresti K. Quality of life and substance use: concepts and recent tendencies. Curr Opin Psychiatr 2009, 22:281-286.
2. Schaar I, Öjehagen A. Predictors of improvement in quality of life of severe mentally ill substance abusers during 18 months of co-operation between psychiatric and social services. Soc Psych Psych Epid 2009, 38:83-87.
3. Meijer CJ, Koeter MWJ, Sprangers MAG, Schene AH. Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Soc Psych Psych Epid 2009, 44:361-368.
4. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophrenia Bull 2007, 33:1225-1237.
5. Brissos S, Videira-Dias V, Carita AI, Martínez A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiat Res 2008, 160:55-62.
6. Kao YC, Liu YP, Chou MK, Cheng TH. Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics. Compr Psychiat 2011, 52:171-180. 10.1016/j.comppsych.2010.05.008, 21295224.
7. Samuli I, Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Brit J Psychiat. 2010, 197:386-394. 10.1192/bjp.bp.109.076489, 21037216.
8. Lozano OM, Domingo-Salvany A, Martínez-Alonso M, et al. Health-related quality of life in young cocaine users and associated factors. Qual Life Res 2008, 17:977-985. 10.1007/s11136-008-9376-8, 18679826.
9. González-Saiz F, Lozano O, Iraurgi I. Measuring the impact of psychoactive substance on health-related quality of life: an update. Curr Drug Abuse Rev 2009, 2:5-10. 10.2174/1874473710902010005, 19630733.
10. Pyne JM, Tripathi S, French M, McCollister K, Rapp RC, Booth BM. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 2011, 106:507-515. 10.1111/j.1360-0443.2010.03299.x, 3076048, 21205046.
11. Bebout RR, Drake RE, Xie H, McHugo GJ, Harris M. Housing status among formerly homeless dually diagnosed adults. Psychiat Serv 1997, 48:936-941.
12. Drake RE, Osher FC, Wallach MA. Homelessness and dual diagnosis. Am Psychol 1991, 46:1149-1158.
13. Rudolf H, Watts J. Quality of life in substance abuse and dependency. Int Rev Psychiatry 2002, 14:190-197.
14. Lamb HR, Lamb DM. Factors contributing to homelessness among the chronically and severely mental ill. Hosp Community Psychiatry 1990, 41:301-305.
15. Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005, 7:187-191. 10.1111/j.1399-5618.2004.00173.x, 15762860.
16. Kilbourne AM, Perron BM, Mezuk B, Welsh D, Ilgen M, Bayer MS. Co-occurring conditions and health-related quality of life in patients with bipolar disorder. Psychosom Med 2009, 71:894-900. 10.1097/PSY.0b013e3181b49948, 19661187.
17. Kalman D, Lee A, Chan E, et al. Alcohol dependence, other psychiatric disorders, and health related quality of life: a replication study in a large random sample of enrollees in the veterans health administration. Am J Drug Alcohol Abuse 2004, 30:473-487. 10.1081/ADA-120037389, 15230087.
18. Bizzarri J, Rucci P, Vallotta A, et al. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse 2005, 40:1765-1776. 10.1080/10826080500260800, 16419555.
19. Fassino S, Abbate-Daga G, Delsedime N, Rogna L, Boggio S. Quality of life and personality disorders in heroin abusers. Drug Alcohol Depen 2004, 76:73-80.
20. Astals M, Domingo-Salvany A, Castillo-Buenaventura C, et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse 2008, 43:612-632. 10.1080/10826080701204813, 18393080.
21. Garg N, Yates WR, Jones R, Zhou M, Williams S. Effects of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict 1999, 8:44-54. 10.1080/105504999306072, 10189514.
22. Wade D, Harrigan S, McGorry PD, Burgess PM, Whealan G. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J Clin Psychiat 2007, 68:767-774.
23. Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de la Fuente L. Valores poblacionales de referencia de la versión española del cuestionario de salud SF-36. Med Clin 1998, 111:410-416.
24. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2002, Washington, DC: American Psychiatric Association, 4, American Psychiatric Association.
25. First MB. Entrevista Clínica Estructurada para los trastornos del eje I del DSM-IV-SCID-I 1999, Barcelona: Masson.
26. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addiction 1991, 86:1119-1127.
27. National Institute of Mental Health CGI Clinical Global Impression. Assessment manual for psychopharmacology 1976, 217-222. Rockville, Guy W, Bonato RR, National Institute of Mental Health.
28. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
29. Leese M, Schene A, Koeter M, et al. SF-36 scales, and simple sums scales, were reliable quality of life summaries for patients with schizophrenia. J Clin Epidemiol 2008, 61:588-596. 10.1016/j.jclinepi.2007.08.004, 18471663.
30. Newnham EA, Harwood KE, Page AC. Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disorders 2007, 98:91-97. 10.1016/j.jad.2006.07.001, 16904752.
31. Morales-Manrique CC, Castellano-Gómez M, Valderrama-Zurián JC, Aleixandre-Benavent RA. Medición de la calidad de vida e importancia de la atención a las necesidades autopercibidas en pacientes drogodependientes. Trastornos Adictivos 2006, 8:212-221.
32. Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clin 2008, 130:726-735.
33. Huberty CJ. A history of effect sizes indices. Educ Psychol Meas 2002, 62:227-240.
34. Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Tourni M. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiat Scand 2009, 119:22-28.
35. Laaksnonen M, Rahkonen O, Martikainen P, Karvonen S, Lahelma E. Smoking and SF-36 health functioning. Prev Med 2006, 42:206-209. 10.1016/j.ypmed.2005.12.003, 16443264.
36. Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS. Life satisfaction and suicidal attempts among persons with schizophrenia. Compr Psychiat 2003, 44:442-447. 10.1016/S0010-440X(03)00146-9, 14610720.
37. Casas M, Torrens M, Duro P, Pinet C, Alvarez E, Udina C. Utilisation des méthylxanthines, caffeine et théophylline dans le traitement des troubles extrapyramidaux secondaires aux traitements par les neuroleptiques. Déroulement d'une hyphotèse thérapeutique. L'encephale 1989, 15:177-180.
38. Paton C, Beer D. Caffeine: the forgotten variable. Int J Psychiat Clin 2001, 5:231-236.
39. Lara D. Caffeine, mental health, and psychiatric disorders. J Alz Dis 2010, 20:239-248.
40. Baethge C, Tondo L, Lepri B, Baldessarini RJ. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009, 11:494-503. 10.1111/j.1399-5618.2009.00727.x, 19624388.
41. Keizer I, Gex-Fabry M, Eytan A, Bertschy G. Smoking in psychiatric inpatients: association with working status, diagnosis, comorbid substance use and history of suicide attempts. Addict Behav 2009, 34:815-820. 10.1016/j.addbeh.2009.03.018, 19362428.
42. Alonso J, Croudace T, Brown J, et al. Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) Study. Value Health 2009, 12:536-543. 10.1111/j.1524-4733.2008.00495.x, 19900255.
43. Kasckow J, Montross L, Golshan S, et al. Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: Relationship to functioning and quality of life. Int J Geriatr Psych 2007, 22:1223-1228.
44. Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B. Gender difference in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol related condictions. Drug Alcohol Depen 2012, 123:190-200.